Abstract: An interactive computer system and method for recruiting potential employee candidates. A user interactive Graphical User Interface (GUI) is provided on a computering device connected to a network for tracking and storing an employee candidate lifecycle with a potential employer. The GUI is preferably configured and operational to provide interactive promotional materials regarding an employment opportunity with a potential employer and establish a first video conference between the candidate and at least one representative of the potential employer.

Abstract: An underwater personal vehicle that as twin battery powered motors affixed to a central body. The propellers preferably counter-rotate and are in shrouds to allow true tracking without stabilizing fins. The operator holds onto the device and controls it from handles on the aft end of the central body. A light and supplemental ballast tubes are available. The thrust produced by the motors is at approximately the center of mass of the vehicle to further stabilize it during motion.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: An underwater personal vehicle that as twin battery powered motors affixed to a central body. The propellers preferably counter-rotate and are in shrouds to allow true tracking without stabilizing fins. The operator holds onto the device and controls it from handles on the aft end of the central body. A light and supplemental ballast tubes are available. The thrust produced by the motors is at approximately the center of mass of the vehicle to further stabilize it during motion.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: An embodiment is a wader system having an upper portion including a hood, a torso portion, and two sleeves. The wader system of an embodiment may further include a chest wader portion having a pouch into which the upper portion may be removably packed and/or stowed for convenience.

Abstract: The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration.

Abstract: The invention relates to a drug delivery device for providing local analgesia, local anesthesia or nerve blockade at a site in a human or animal in need thereof, the device comprising a fibrillar collagen matrix; and at least one drug substance selected from the group consisting of amino amide anesthetics, amino ester anesthetics and mixtures thereof, the at least one drug substance being substantially homogeneously dispersed in the collagen matrix, and the at least one drug substance being present in an amount sufficient to provide a duration of local analgesia, local anesthesia or nerve blockade which lasts for at least about one day after administration.

Abstract: An audio device concealed within a traditional book wherein said device is non-intrusive on the traditional reading experience and is compatible with the habits of the avid reader, functional for the professional author, and useful for the enhancement of the literary art form.

Abstract: This invention relates to cationically derivatized polycalactomannans obtained from cassia tora and cassia obtusifolia and to their use in personal care, household care, and institutional care compositions.

Abstract: This invention is directed to potent inhibitors of protein tyrosine kinase alone or in synergistic combination with antiangiogenic or chemotherapeutic agents for the abrogation of mature vasculature within chemotherapeutic refractory tumors, pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cell proliferation, and particularly treatment of brain cancer, ovarian cancer, pancreatic cancer prostate cancer, and human leukemias, such as CML, AML or ALL.

Abstract: A tool installs barb emitters in irrigation tubing. The tool has a cradle which receives irrigation tubing and a punch mounted opposite the cradle. The punch has a first cylinder and a second cylinder telescopically received within the first cylinder. The first cylinder has a cap at the upper end and an annular ring extending inwardly from to partially occlude the lower end. The second cylinder includes a second cap at the upper end which slidably engages the first cylinder and is resiliently urged by a spring against the annular ring. The cap has a punch holder extending downwardly therefrom. A needle has a sharp tip extending downwardly from the punch holder through the second cap to a point within the second cylinder when the spring is fully extended and beyond the second cylinder when the spring is fully compressed. One of the jaws has a knife blade extending from the other end thereof opposite. The of the jaws defines a semi-circular concave anvil at the other end.

Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

Abstract: A relatively simple and inexpensive method to increase the operational lifetime of semiconductor laser diode elements and light emitting diodes (LEDs) is disclosed. The semiconductor laser diode element is placed in contact with a non-electrically conductive, chemically inert liquid. Preferably the liquid is a perfluorinated liquid. This results in a dramatically increased operational lifetime for the semiconductor laser diode element by preventing damaging heat build up to vulnerable areas of the laser diode element, such as the p-n junction. This method can work with the liquid being either static or flowing. The disclosed method can be used when the semiconductor laser diode element is used either as a laser itself or when it is used to optically pump another lasing element. The liquid can also be in contact with the lasing element, collimating lens, sub-mounts, or thermoelectric coolers in a lasing assembly.

Abstract: The present invention is directed to rubber modified polymers which contains a functionalized (that is, highly grafted) rubber having a degree of grafting of at least 30 percent at the point of phase inversion and a specified amount of grafted vinyl aromatic polymer.

Abstract: The present invention relates to a unique blend of elastomeric and thermoplastic monovinylidene aromatic-conjugated diene block copolymers, which form transparent elastomeric products.